Literature DB >> 18161707

Acute hepatitis C virus infection: a chronic problem.

Jason T Blackard1, M Tarek Shata, Norah J Shire, Kenneth E Sherman.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18161707      PMCID： PMC2277496          DOI： 10.1002/hep.21902

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  133 in total

1.  T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors.

Authors:  Nasser Semmo; Eleanor Barnes; Craig Taylor; John Kurtz; Gillian Harcourt; Neil Smith; Paul Klenerman
Journal:  Lancet       Date:  2005 Jan 22-28       Impact factor: 79.321

2.  Clinical presentation and course of acute hepatitis C infection in HIV-infected patients.

Authors:  Annie Luetkemeyer; C Bradley Hare; John Stansell; Phyllis C Tien; Edwin Charlesbois; Paula Lum; Diane Havlir; Marion Peters
Journal:  J Acquir Immune Defic Syndr       Date:  2006-01-01       Impact factor: 3.731

3.  Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study.

Authors:  Johannes Wiegand; Peter Buggisch; Wulf Boecher; Stefan Zeuzem; Cornelia M Gelbmann; Thomas Berg; Wolfgang Kauffmann; Birgit Kallinowski; Markus Cornberg; Elmar Jaeckel; Heiner Wedemeyer; Michael P Manns
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

4.  HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.

Authors:  Salim I Khakoo; Chloe L Thio; Maureen P Martin; Collin R Brooks; Xiaojiang Gao; Jacquie Astemborski; Jie Cheng; James J Goedert; David Vlahov; Margaret Hilgartner; Steven Cox; Ann-Margeret Little; Graeme J Alexander; Matthew E Cramp; Stephen J O'Brien; William M C Rosenberg; David L Thomas; Mary Carrington
Journal:  Science       Date:  2004-08-06       Impact factor: 47.728

5.  Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.

Authors:  Sanaa M Kamal; Amr E Fouly; Refaat R Kamel; Bridgette Hockenjos; Ahmed Al Tawil; Khalifa E Khalifa; Qi He; Margaret J Koziel; Khairy M El Naggar; Jens Rasenack; Nezam H Afdhal
Journal:  Gastroenterology       Date:  2006-03       Impact factor: 22.682

6.  Prevalence of production of virus-specific interferon-gamma among seronegative hepatitis C-resistant subjects reporting injection drug use.

Authors:  Anthony J Freeman; Rosemary A Ffrench; Jeffrey J Post; Charles E Harvey; Stuart J Gilmour; Peter A White; George Marinos; Ingrid van Beek; William D Rawlinson; Andrew R Lloyd
Journal:  J Infect Dis       Date:  2004-08-10       Impact factor: 5.226

7.  Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy.

Authors:  Jeanne Serpaggi; Marie-Laure Chaix; Dominique Batisse; Caroline Dupont; Anaïs Vallet-Pichard; Hélène Fontaine; Jean-Paul Viard; Christophe Piketty; Elisabeth Rouveix; Christine Rouzioux; Laurence Weiss; Stanislas Pol
Journal:  AIDS       Date:  2006-01-09       Impact factor: 4.177

8.  Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.

Authors:  Chihiro Morishima; Stephen J Polyak; Ranjit Ray; Michael C Doherty; Adrian M Di Bisceglie; Peter F Malet; Herbert L Bonkovsky; Daniel G Sullivan; David R Gretch; Alan L Rothman; Margaret James Koziel; Karen L Lindsay
Journal:  J Infect Dis       Date:  2006-02-22       Impact factor: 5.226

9.  Hepatitis C virus infection in Samoa and American Samoa.

Authors:  Gregory L Armstrong; Ian T Williams; Utoofili Asofa'Afetai Maga; Satupaitea Viali; Wendi L Kuhnert; Stephen T McGarvey
Journal:  Am J Trop Med Hyg       Date:  2006-02       Impact factor: 2.345

10.  Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.

Authors:  M Gale; B Kwieciszewski; M Dossett; H Nakao; M G Katze
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103
View more
  29 in total

1.  The clinical course of acute hepatitis C.

Authors:  Allison Venner; Martin Kistin
Journal:  Dig Dis Sci       Date:  2014-03       Impact factor: 3.199

Review 2.  Treatment of acute HCV infection.

Authors:  Jason Grebely; Gail V Matthews; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-22       Impact factor: 46.802

Review 3.  Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals.

Authors:  Nicola Coppola; Mariantonietta Pisaturo; Rosa Zampino; Margherita Macera; Caterina Sagnelli; Evangelista Sagnelli
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 4.  Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment.

Authors:  E Sagnelli; T Santantonio; N Coppola; M Fasano; M Pisaturo; C Sagnelli
Journal:  Infection       Date:  2014-03-12       Impact factor: 3.553

5.  Prospective follow-up of patients with acute hepatitis C virus infection in Brazil.

Authors:  Lia L Lewis-Ximenez; Georg M Lauer; Julian Schulze Zur Wiesch; Paulo Sergio Fonseca de Sousa; Cleber F Ginuino; Gláucia Paranhos-Baccalá; Hanno Ulmer; Karl P Pfeiffer; Georg Goebel; João Luiz Pereira; Jaqueline Mendes de Oliveira; Clara Fumiko Tachibana Yoshida; Elisabeth Lampe; Carlos Eduardo Velloso; Marcelo Alves Pinto; Henrique Sergio Coelho; Adilson José Almeida; Carlos Augusto Fernandes; Arthur Y Kim; Alexander M Strasak
Journal:  Clin Infect Dis       Date:  2010-05-01       Impact factor: 9.079

6.  Antibody dynamics and spontaneous viral clearance in patients with acute hepatitis C infection in Rio de Janeiro, Brazil.

Authors:  Alexander M Strasak; Arthur Y Kim; Georg M Lauer; Paulo S de Sousa; Cleber F Ginuino; Carlos A Fernandes; Carlos E Velloso; Adilson J de Almeida; Jaqueline M de Oliveira; Clara F Yoshida; Julian Schulze zur Wiesch; Gláucia Paranhos-Baccalá; Stefan Lang; Larry J Brant; Hanno Ulmer; Susanne Strohmaier; Lalit Kaltenbach; Elisabeth Lampe; Lia L Lewis-Ximenez
Journal:  BMC Infect Dis       Date:  2011-01-12       Impact factor: 3.090

Review 7.  Hidden hazards of HCV transmission.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Med Microbiol Immunol       Date:  2010-05-12       Impact factor: 3.402

Review 8.  Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine.

Authors:  Jason Grebely; Maria Prins; Margaret Hellard; Andrea L Cox; William O Osburn; Georg Lauer; Kimberly Page; Andrew R Lloyd; Gregory J Dore
Journal:  Lancet Infect Dis       Date:  2012-05       Impact factor: 25.071

9.  Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.

Authors:  Jason Grebely; Kathy Petoumenos; Margaret Hellard; Gail V Matthews; Vijayaprakash Suppiah; Tanya Applegate; Barbara Yeung; Phillipa Marks; William Rawlinson; Andrew R Lloyd; David Booth; John M Kaldor; Jacob George; Gregory J Dore
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

10.  Acute hepatitis C virus infection in a nurse trainee following a needlestick injury.

Authors:  Renzo Scaggiante; Liliana Chemello; Roberto Rinaldi; Giovanni Battista Bartolucci; Andrea Trevisan
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.